High materiality8/10
Axsome Therapeutics (AXSM) PT Raised to $268 at Needham
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target raised to $268; current price $220.89; Needham sees substantial upside ahead.
- Target $268; Price $220.89; Firm Needham; Analyst Ami Fadia
Key facts
- 01
Target: $268
- 02
Posted price: $220.89
- 03
Analyst firm: Needham
- 04
Analyst: Ami Fadia
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.